Vanta Bioscience Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

6.31

6.31

6.31

6.31

6.31

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

10.82

13.48

13.43

17.68

17.60

Loan funds

Secured loans

30.47

25.38

25.76

20.77

13.30

Unsecured loans

-

-

-

-

-

Total

47.60

45.17

45.50

44.76

37.21

Uses of funds

Fixed assets

Gross block

51.13

45.34

43.69

41.16

19.24

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

8.69

7.46

6.29

5.04

3.72

Net block

42.43

37.87

37.40

36.12

15.52

Capital work-in-progress

-

-

-

-

13.87

Investments

3.00

3.00

3.00

3.00

3.00

Net current assets

Current assets, loans & advances

10.40

12.04

11.24

11.28

13.86

Less : current liabilities & provisions

8.23

7.74

6.14

5.64

9.04

Total net current assets

2.17

4.30

5.10

5.64

4.82

Miscellaneous expenses not written

-

-

-

-

-

Total

47.60

45.17

45.50

44.76

37.21

Notes:

Book value of unquoted investments

3.00

3.00

3.00

3.00

3.00

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

63.12

63.12

63.12

63.12

63.12